Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.4.1. Impact Of Covid-19 On The Global Rna Interference (Rnai) Drug Delivery Market
2.5. Major Market Findings
2.5.1. North America Constitutes The Highest Market Share In Terms Of Region
2.5.2. Cardiology Is The Fastest-Growing Rnai Drug Delivery Application
2.5.3. Nanoparticle Drug Delivery Is The Majorly Preferred Rnai Drug Delivery Technology

3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Demand For Rna-Based Therapeutics To Stimulate Market Growth
3.1.2. Rising Prevalence Of Chronic Diseases Fosters Market Demand
3.1.3. Growing Investment In Rna-Based Research To Escalate Market Growth
3.2. Key Restraints
3.2.1. The Complexity Of Rnai Technology Is Predicted To Hinder Market Demand
3.2.2. Regulatory Challenges Are Expected To Further Complicate Market Growth

4. Key Analytics
4.1. Key Market Trends
4.1.1. Rnai Drugs Have Applications In Cancer Treatment
4.1.2. Infectious Diseases Are Leading To Increased Traction In Rnai Drugs
4.1.3. Venture Funding For Rnai Drugs Has Increased Substantially
4.2. Porter’S Five Forces Analysis
4.2.1. Buyers Power
4.2.2. Suppliers Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Growth Prospect Mapping
4.3.1. Growth Prospect Mapping For Germany
4.3.2. Growth Prospect Mapping For United Kingdom
4.3.3. Growth Prospect Mapping For South Korea
4.4. Market Maturity Analysis
4.5. Market Concentration Analysis
4.6. Value Chain Analysis
4.6.1. Primary Activities
4.6.1.1. Research And Development (R&D)
4.6.1.2. Manufacturing
4.6.1.3. Logistics And Distribution
4.6.1.4. Marketing And Sales
4.6.1.5. After-Sales Service
4.6.2. Support Activities
4.6.2.1. Procurement
4.6.2.2. Technology Development
4.6.2.3. Human Resource Management
4.6.2.4. Firm Infrastructure
4.6.2.5. Regulatory Affairs And Compliance
4.7. Global Rna Interference (Rnai) Drug Delivery Market Regulatory Framework
4.8. Key Buying Criteria
4.8.1. Efficacy And Safety
4.8.2. Mechanism Of Action And Target Specificity
4.8.3. Delivery System And Administration Route
4.8.4. Competitive Advantage And Differentiation
4.8.5. Regulatory Approval And Compliance
4.8.6. Cost And Reimbursement
4.8.7. Intellectual Property And Exclusivity
4.8.8. Manufacturing Capabilities And Supply Chain
4.8.9. Company Reputation And Experience

5. Market By Application
5.1. Oncology
5.1.1. Market Forecast Figure
5.1.2. Segment Analysis
5.2. Infectious Disease
5.2.1. Market Forecast Figure
5.2.2. Segment Analysis
5.3. Neurology
5.3.1. Market Forecast Figure
5.3.2. Segment Analysis
5.4. Cardiology
5.4.1. Market Forecast Figure
5.4.2. Segment Analysis
5.5. Metabolic Disorders
5.5.1. Market Forecast Figure
5.5.2. Segment Analysis
5.6. Ophthalmology
5.6.1. Market Forecast Figure
5.6.2. Segment Analysis
5.7. Urology
5.7.1. Market Forecast Figure
5.7.2. Segment Analysis
5.8. Other Applications
5.8.1. Market Forecast Figure
5.8.2. Segment Analysis

6. Market By Technology
6.1. Nanoparticle Drug Delivery
6.1.1. Market Forecast Figure
6.1.2. Segment Analysis
6.2. Pulmonary Drug Delivery
6.2.1. Market Forecast Figure
6.2.2. Segment Analysis
6.3. Nucleic Acid Drug Delivery
6.3.1. Market Forecast Figure
6.3.2. Segment Analysis
6.4. Aptamer Drug Delivery
6.4.1. Market Forecast Figure
6.4.2. Segment Analysis

7. Geographical Analysis
7.1. North America
7.1.1. Market Size & Estimates
7.1.2. North America Rna Interference (Rnai) Drug Delivery Market Drivers
7.1.3. North America Rna Interference (Rnai) Drug Delivery Market Challenges
7.1.4. Key Players In North America Rna Interference (Rnai) Drug Delivery Market
7.1.5. Country Analysis
7.1.5.1. United States
7.1.5.1.1. United States Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.1.5.2. Canada
7.1.5.2.1. Canada Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.2. Europe
7.2.1. Market Size & Estimates
7.2.2. Europe Rna Interference (Rnai) Drug Delivery Market Drivers
7.2.3. Europe Rna Interference (Rnai) Drug Delivery Market Challenges
7.2.4. Key Players In Europe Rna Interference (Rnai) Drug Delivery Market
7.2.5. Country Analysis
7.2.5.1. Germany
7.2.5.1.1. Germany Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.2.5.2. United Kingdom
7.2.5.2.1. United Kingdom Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.2.5.3. France
7.2.5.3.1. France Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.2.5.4. Italy
7.2.5.4.1. Italy Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.2.5.5. Spain
7.2.5.5.1. Spain Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.2.5.6. Belgium
7.2.5.6.1. Belgium Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.2.5.7. Poland
7.2.5.7.1. Poland Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.2.5.8. Rest Of Europe
7.2.5.8.1. Rest Of Europe Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3. Asia-Pacific
7.3.1. Market Size & Estimates
7.3.2. Asia-Pacific Rna Interference (Rnai) Drug Delivery Market Drivers
7.3.3. Asia-Pacific Rna Interference (Rnai) Drug Delivery Market Challenges
7.3.4. Key Players In Asia-Pacific Rna Interference (Rnai) Drug Delivery Market
7.3.5. Country Analysis
7.3.5.1. China
7.3.5.1.1. China Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3.5.2. Japan
7.3.5.2.1. Japan Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3.5.3. India
7.3.5.3.1. India Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3.5.4. Australia & New Zealand
7.3.5.4.1. Australia & New Zealand Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3.5.5. South Korea
7.3.5.5.1. South Korea Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3.5.6. Thailand
7.3.5.6.1. Thailand Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3.5.7. Indonesia
7.3.5.7.1. Indonesia Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3.5.8. Vietnam
7.3.5.8.1. Vietnam Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.3.5.9. Rest Of Asia-Pacific
7.3.5.9.1. Rest Of Asia-Pacific Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.4. Rest Of World
7.4.1. Market Size & Estimates
7.4.2. Rest Of World Rna Interference (Rnai) Drug Delivery Market Drivers
7.4.3. Rest Of World Rna Interference (Rnai) Drug Delivery Market Challenges
7.4.4. Key Players In Rest Of World Rna Interference (Rnai) Drug Delivery Market
7.4.5. Regional Analysis
7.4.5.1. Latin America
7.4.5.1.1. Latin America Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
7.4.5.2. Middle East & Africa
7.4.5.2.1. Middle East & Africa Rna Interference (Rnai) Drug Delivery Market Size & Opportunities
8. Competitive Landscape
8.1. Key Market Strategies
8.1.1. Product Launches & Developments
8.1.2. Partnerships & Agreements
8.2. Company Profiles
8.2.1. Alnylam Pharmaceuticals Inc
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Strengths & Challenges
8.2.2. Arbutus Biopharma Corp
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Strengths & Challenges
8.2.3. Arcturus Therapeutics Inc
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Strengths & Challenges
8.2.4. Arrowhead Pharmaceuticals Inc
8.2.4.1. Company Overview
8.2.4.2. Product Portfolio
8.2.4.3. Strengths & Challenges
8.2.5. Benitec Biopharma
8.2.5.1. Company Overview
8.2.5.2. Product Portfolio
8.2.5.3. Strengths & Challenges
8.2.6. Eleven Therapeutics
8.2.6.1. Company Overview
8.2.6.2. Product Portfolio
8.2.6.3. Strengths & Challenges
8.2.7. Genevant Sciences Corp
8.2.7.1. Company Overview
8.2.7.2. Product Portfolio
8.2.7.3. Strengths & Challenges
8.2.8. Ionis Pharmaceuticals Inc
8.2.8.1. Company Overview
8.2.8.2. Product Portfolio
8.2.8.3. Strengths & Challenges
8.2.9. Mirimus Inc
8.2.9.1. Company Overview
8.2.9.2. Product Portfolio
8.2.9.3. Strengths & Challenges
8.2.10. Nanode Therapeutics Inc
8.2.10.1. Company Overview
8.2.10.2. Product Portfolio
8.2.10.3. Strengths & Challenges
8.2.11. Olix Pharmaceuticals
8.2.11.1. Company Overview
8.2.11.2. Product Portfolio
8.2.11.3. Strengths & Challenges
8.2.12. Silence Therapeutics Plc
8.2.12.1. Company Overview
8.2.12.2. Product Portfolio
8.2.12.3. Strengths & Challenges
8.2.13. Sirnaomics Inc
8.2.13.1. Company Overview
8.2.13.2. Product Portfolio
8.2.13.3. Strengths & Challenges
8.2.14. Somagenics Inc
8.2.14.1. Company Overview
8.2.14.2. Product Portfolio
8.2.14.3. Strengths & Challenges



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping For Germany
Figure 4: Growth Prospect Mapping For United Kingdom
Figure 5: Growth Prospect Mapping For South Korea
Figure 6: Market Maturity Analysis
Figure 7: Market Concentration Analysis
Figure 8: Value Chain Analysis
Figure 9: Drug Approval Process
Figure 10: Key Buying Criteria
Figure 11: Global Rna Interference (Rnai) Drug Delivery Market, Growth Potential, By Application, In 2023
Figure 12: Global Rna Interference (Rnai) Drug Delivery Market, By Oncology, 2024-2032 (In $ Million)
Figure 13: Global Rna Interference (Rnai) Drug Delivery Market, By Infectious Disease, 2024-2032 (In $ Million)
Figure 14: Global Rna Interference (Rnai) Drug Delivery Market, By Neurology, 2024-2032 (In $ Million)
Figure 15: Global Rna Interference (Rnai) Drug Delivery Market, By Cardiology, 2024-2032 (In $ Million)
Figure 16: Global Rna Interference (Rnai) Drug Delivery Market, By Metabolic Disorders, 2024-2032 (In $ Million)
Figure 17: Global Rna Interference (Rnai) Drug Delivery Market, By Ophthalmology, 2024-2032 (In $ Million)
Figure 18: Global Rna Interference (Rnai) Drug Delivery Market, By Urology, 2024-2032 (In $ Million)
Figure 19: Global Rna Interference (Rnai) Drug Delivery Market, By Other Applications, 2024-2032 (In $ Million)
Figure 20: Global Rna Interference (Rnai) Drug Delivery Market, Growth Potential, By Technology, In 2023
Figure 21: Global Rna Interference (Rnai) Drug Delivery Market, By Nanoparticle Drug Delivery, 2024-2032 (In $ Million)
Figure 22: Global Rna Interference (Rnai) Drug Delivery Market, By Pulmonary Drug Delivery, 2024-2032 (In $ Million)
Figure 23: Global Rna Interference (Rnai) Drug Delivery Market, By Nucleic Acid Drug Delivery, 2024-2032 (In $ Million)
Figure 24: Global Rna Interference (Rnai) Drug Delivery Market, By Aptamer Drug Delivery, 2024-2032 (In $ Million)
Figure 25: North America Rna Interference (Rnai) Drug Delivery Market, Country Outlook, 2023 & 2032 (In %)
Figure 26: United States Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 27: Canada Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 28: Europe Rna Interference (Rnai) Drug Delivery Market, Country Outlook, 2023 & 2032 (In %)
Figure 29: Germany Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 30: United Kingdom Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 31: France Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 32: Italy Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 33: Spain Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 34: Belgium Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 35: Poland Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 36: Rest Of Europe Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 37: Asia-Pacific Rna Interference (Rnai) Drug Delivery Market, Country Outlook, 2023 & 2032 (In %)
Figure 38: China Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 39: Japan Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 40: India Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 41: Australia & New Zealand Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 42: South Korea Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 43: Thailand Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 44: Indonesia Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 45: Vietnam Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 46: Rest Of Asia-Pacific Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 47: Rest Of World Rna Interference (Rnai) Drug Delivery Market, Regional Outlook, 2023 & 2032 (In %)
Figure 48: Latin America Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)
Figure 49: Middle East & Africa Rna Interference (Rnai) Drug Delivery Market, 2024-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – RNA INTERFERENCE (RNAI) DRUG DELIVERY
TABLE 2: GLOBAL RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: GLOBAL INFECTIOUS DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL INFECTIOUS DISEASE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL NEUROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL NEUROLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL CARDIOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL CARDIOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: GLOBAL METABOLIC DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL METABOLIC DISORDERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: GLOBAL OPHTHALMOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL OPHTHALMOLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: GLOBAL UROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL UROLOGY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 20: GLOBAL RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 22: GLOBAL NANOPARTICLE DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL NANOPARTICLE DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 24: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 26: GLOBAL NUCLEIC ACID DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL NUCLEIC ACID DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 28: GLOBAL APTAMER DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: GLOBAL APTAMER DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 30: GLOBAL RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 31: GLOBAL RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 32: NORTH AMERICA RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: NORTH AMERICA RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 34: KEY PLAYERS OPERATING IN NORTH AMERICA RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET
TABLE 35: EUROPE RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 36: EUROPE RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 37: KEY PLAYERS OPERATING IN EUROPE RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET
TABLE 38: ASIA-PACIFIC RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 39: ASIA-PACIFIC RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 40: KEY PLAYERS OPERATING IN ASIA-PACIFIC RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET
TABLE 41: REST OF WORLD RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 42: REST OF WORLD RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 43: KEY PLAYERS OPERATING IN REST OF WORLD RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET
TABLE 44: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 45: LIST OF PARTNERSHIPS & AGREEMENTS